User Study: Our Cream Tested by Dermatest for Psoriasis
How well tolerated is our skincare cream, and what does it do for skin prone to psoriasis? To test this according to clinical-dermatological criteria, we carried out a user study together with the independent testing institute Dermatest. The product tested was our former skincare cream, today's natüür Cream with 1 % NEEMAVERA®. Here you'll find the study's procedure and results.
In brief: the study at a glance
20 people with psoriasis applied the Cream to the affected areas once a day for six weeks, alongside their treatment. 95 % rated its tolerability as good, 80 % noticed a reduction in their scaling. In the measurements, skin moisture rose by around 40 %, while scaling and redness decreased by around 30 % and 20 % respectively.
The skincare cream tested at the time, in its former packaging. Today it is called natüür Cream.
About the study
| Key facts | Details |
|---|---|
| Type of study | In vivo user study with Dermatest |
| Product | natüür skincare cream with 1 % NEEMAVERA® (today: Cream) |
| Participants | 20 people with psoriasis |
| Duration | 6 weeks (42 days) |
| Application | once a day on the affected areas of skin, alongside treatment |
| Evaluation | Questionnaire at the end, dermatological assessment and measurement of skin moisture every three weeks |
The participants were supervised by specialist staff during the study. Every three weeks, the affected areas of skin were assessed dermatologically and skin moisture was measured.
Results of the questionnaire
At the end of the six weeks, the participants answered a questionnaire with 18 questions on the effect on their skin and two questions on purchase intention and recommendation. The ten most important results:
| Share | Participants' statement |
|---|---|
| 95 % | rate the tolerability as “good” |
| 95 % | say the cream helps with their dry skin |
| 90 % | feel their skin is well moisturised |
| 80 % | notice an easing in the severity of their psoriasis |
| 80 % | notice a reduction in their scaling |
| 80 % | report that the cream intensively cares for the skin |
| 80 % | would recommend the skincare cream |
| 75 % | would buy the skincare cream after the test |
| 70 % | say the cream has reduced itching |
| 70 % | report a reduction in skin irritation |
Results of the dermatological assessment
In addition to the questionnaire, three values were measured on the affected areas of skin:
- Skin moisture: A probe is used to measure the moisture of the upper layer of the skin (corneometry). An imperceptible electrical pulse shows how much water the skin contains.
- Scaling and redness: These were evaluated using the “In-vivo Touching Evaluation”. A trained assessor looks at the skin and feels it.
| Measured value after 6 weeks | Change |
|---|---|
| Skin moisture | increased by approx. 40 % |
| Scaling | decreased by approx. 30 % |
| Redness | decreased by approx. 20 % |
Conclusion and what came of it
Our skincare cream impressed in the Dermatest user test: the participants reported a positive effect on their psoriasis-affected skin, and 80 % would recommend it. The dermatological assessment also confirmed the effect. We are aware that no cream is the solution for everyone affected, and we are very pleased with the results.
We would have liked to see an even stronger effect. That's why, together with our Co-Creators, we developed a stronger version: the Cream forte with 2.5 % NEEMAVERA® and a richer texture. Our article Cream, Cream forte or ointment explains how the two differ.
You can read more about our tests here:
- Dermatologically tested: what's behind the Dermatest seal
- In vitro study: what NEEMAVERA® shows in the lab
- Psoriasis cream tested with the Psoriasis-Netz
The Cream today
Our Cream with 1 % NEEMAVERA® has been developed specifically for skin prone to psoriasis, atopic dermatitis or eczema: light, quickly absorbed, without fragrances, vegan and dermatologically tested with the result “very good”. Our care accompanies medical treatment, but does not replace it.